Polen Capital Management 13F holdings, Q4 2006
Holdings as of December 29, 2006 · filings on SEC EDGAR · latest filing →
Polen Capital Management disclosed 21 US equity positions worth $645.6m in its Q4 2006 13F filing. The largest position was CSCO at 8.2% of the reported book, followed by MDT and ORCL. Against the Q3 2006 filing, it opened 2 new positions, added to 3 and reduced 15 among the top 21 holdings.
What did Polen Capital Management own in Q4 2006? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2006 |
|---|---|---|---|---|---|---|---|
| 1 | CSCO Cisco Sys Inc | Technology | 8.2% | $53.2m | 1,947,106 | -9% | reduced |
| 2 | MDT Medtronic Inc | Healthcare | 7.8% | $50.1m | 936,549 | -9% | reduced |
| 3 | ORCL Oracle Corp | Technology | 6.9% | $44.4m | 2,592,032 | -9% | reduced |
| 4 | MSFT Microsoft Corp | Technology | 6.9% | $44.3m | 1,484,996 | -9% | reduced |
| 5 | AXP American Express | Financial Services | 6.5% | $41.9m | 690,104 | -2% | reduced |
| 6 | McGraw Hill | 6.5% | $41.7m | 613,561 | -25% | reduced | |
| 7 | MMM 3M Company | Industrials | 6.0% | $38.6m | 495,267 | 5% | added |
| 8 | PEP Pepsico Inc | Consumer Defensive | 5.4% | $35.0m | 559,061 | -9% | reduced |
| 9 | UPS UPS | Industrials | 5.3% | $34.0m | 452,816 | -9% | reduced |
| 10 | ABT Abbott Labs | Healthcare | 4.8% | $30.8m | 632,280 | – | new |
| 11 | ADBE Adobe Systems | Technology | 4.7% | $30.6m | 745,116 | 39% | added |
| 12 | KO Coca-Cola CO | Consumer Defensive | 4.4% | $28.7m | 594,773 | -9% | reduced |
| 13 | AMGN Amgen Inc | Healthcare | 4.2% | $27.1m | 396,473 | -40% | reduced |
| 14 | SYK Stryker | Healthcare | 3.3% | $21.4m | 389,043 | 37% | added |
| 15 | EBAY Ebay Inc | Consumer Cyclical | 3.3% | $21.4m | 711,195 | -9% | reduced |
| 16 | NKE Nike Inc | Consumer Cyclical | 3.2% | $20.9m | 211,226 | -8% | reduced |
| 17 | ADSK Autodesk | Technology | 3.1% | $19.8m | 490,245 | – | new |
| 18 | HOG Harley-Davidson Inc | Consumer Cyclical | 3.0% | $19.4m | 274,710 | -36% | reduced |
| 19 | JNJ Johnson & Johnson | Healthcare | 3.0% | $19.1m | 289,313 | -7% | reduced |
| 20 | Bershire Hathaway B | 2.6% | $16.7m | 4,549 | -12% | reduced | |
| 21 | BRK/A Bershire Hathaway A | 1.0% | $6.5m | 59 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.